Oyster Point Pharma, Inc.
OYSTDelisted Jan 3, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001720725
Oyster Point Pharma, Inc. was delisted on Jan 3, 2023; its insiders filed their last Form 4 on Jan 5, 2023; 53 institutions reported holding it in 13F filings for Q4 2022, worth $189.4M in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Oyster Point Pharma, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 61 | 60 | −1 |
| Shares | 20.2M | 20.0M | −186.1K (−0.9%) |
| Value | $87.6M | $112.6M | +$25.0M (+28.6%) |
New holders (7)
Institutions that held Oyster Point Pharma, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HRT Financial LP | 41,917 | $235.0K | 0.00% |
| Walleye Capital LLC | 20,182 | $113.0K | 0.00% |
| Jane Street Group, LLC | 18,867 | $106.0K | 0.00% |
| Qube Research & Technologies Ltd | 14,248 | $80.0K | 0.00% |
| Bank of New York Mellon Corp | 10,834 | $61.0K | 0.00% |
| Rockefeller Capital Management L.P. | 4,000 | $22.0K | 0.00% |
| China Universal Asset Management Co., Ltd. | 251 | $1.00K | 0.00% |
Sold out (8)
Institutions that held Oyster Point Pharma, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Wellington Management Group LLP | 232,267 | $1.00M |
| HSBC Holdings PLC | 103,510 | $449.0K |
| Dimensional Fund Advisors LP | 19,517 | $85.0K |
| Renaissance Technologies LLC | 18,500 | $80.0K |
| MCF Advisors LLC | 1,072 | $5.00K |
| Federated Hermes, Inc. | 112 | $1.00K |
| New York State Common Retirement Fund | 107 | $0 |
| Credit Suisse AG | 6 | $0 |